Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2
Made in Finland
Note that Bydureon is not recommended as first-line therapy for patients who have inadequate glycemic control on diet and exercise because of the uncertain relevance of the rat thyroid C-cell tumor findings to humans (Drugs.com)
This product has been used as a molecular tool for various biochemical applications
Receptor agonists include full agonists, partial agonists, and inverse agonists
US$ 23.16
US$ 28.49
US$ 24.77
US$ 24.80
US$ 21.60
US$ 29.93
US$ 20.27
US$ 29.23
